// App-Quantinova.ai

: Novel MVA-based vaccine expressing influenza NP and M1 activates cross-reactive T cell responses in human nasopharynx-associated lymphoid tissue (NALT)

Researchers

Presenter

  • Suttida Puksuriwong

Principal Investigators

  • Muhammad Shamsher Ahmed

  • Ravi Sharma

  • Madhan Krishnan

  • Salil Sood

  • Max McCormick

  • Sam Leong

  • Teresa Lambe

  • Paul McNamara

  • Sarah C. Gilbert

  • Qibo Zhang

Medical Centers

  • University of Liverpool, Liverpool, United Kingdom

  • ENT Departments of Alder Hey Children’s Hospital, United Kingdom

  • ENT Departments of Royal Liverpool and Broadgreen University Hospitals, United Kingdom

  • ENT Departments of Aintree University Hospital, United Kingdom

  • The Jenner Institute, University of Oxford, Oxford, United Kingdom

  • Institute of Child Health, Alder Hey Children’s Hospital, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Influenza

Biomarkers

  • Cluster of Differentiation 107 Antigen-Like Family Member A

  • Cluster of differentiation 8A

Drug/Treatment

  • Interferon Gamma

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved